Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2016 16:01 ET | Source: Vital Therapies, Inc.

Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call with Webcast and Upcoming Conference Presentation

SAN DIEGO, April 28, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
March 08, 2016 16:01 ET | Source: Vital Therapies, Inc.

Vital Therapies Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update

SAN DIEGO, March 08, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
February 24, 2016 08:01 ET | Source: Vital Therapies, Inc.

Vital Therapies Announces Upcoming Fourth Quarter and Full Year 2015 Financial Results Conference Call With Webcast

SAN DIEGO, Feb. 24, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure, will...
November 19, 2015 08:01 ET | Source: Vital Therapies, Inc.

Vital Therapies Receives FDA Guidance; Announces Upcoming Launch of VTL-308 Phase 3 Trial

SAN DIEGO, Nov. 19, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure,...
November 18, 2015 08:01 ET | Source: Vital Therapies, Inc.

Vital Therapies Announces Late Breaker and Poster Presentations at the Annual Meeting of the American Association for the Study of Liver Disease

SAN DIEGO, Nov. 18, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure,...
November 05, 2015 16:01 ET | Source: Vital Therapies, Inc.

Vital Therapies Announces Third Quarter 2015 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure, today...
October 28, 2015 16:01 ET | Source: Vital Therapies, Inc.

Vital Therapies Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriter's Option to Purchase Additional Shares

SAN DIEGO, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing the ELAD® System, a cell-based therapy targeting the treatment of liver...
October 22, 2015 23:59 ET | Source: Vital Therapies, Inc.

Vital Therapies Announces Pricing of Public Offering of Common Stock

SAN DIEGO, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing the ELAD® System, a cell-based therapy targeting the treatment of liver...
October 22, 2015 16:01 ET | Source: Vital Therapies, Inc.

Vital Therapies Announces Proposed Public Offering of Common Stock

SAN DIEGO, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing the ELAD® System, a cell-based therapy targeting the treatment of liver...
October 16, 2015 08:00 ET | Source: Vital Therapies, Inc.

Vital Therapies Provides Corporate Update and Announces Date of Third Quarter 2015 Financial Results

SAN DIEGO, Oct. 16, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure, today...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right